Cite Filings / CADL / 0000950170-24-084065

Feed Companies Filings Check

Sign in

144

Sale of Securities

Candel Therapeutics, Inc. Filed 2024-07-17 Acc 0000950170-24-084065

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2024-07-17 144 Sale of Securities
2024-07-17 144 Sale of Securities
2024-07-17 144 Sale of Securities
2024-07-17 144 Sale of Securities
2024-07-17 144 Sale of Securities
2024-07-15 4 Chief Technology Officer sold 13,330 shares at $5.97 ($79,625)
2024-07-15 4 Chief Executive Officer sold 20,293 shares at $5.97 ($121,218)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…